+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Livestock Medicine Market - Global Forecast 2026-2032- Product Image
Livestock Medicine Market - Global Forecast 2026-2032- Product Image
Sale

Livestock Medicine Market - Global Forecast 2026-2032

  • Report

  • 192 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 5715776
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Livestock Medicine Market is projected to reach USD 21.95 Billion in 2026. It is expected to continue growing at a CAGR of 5.71%, reaching USD 30.72 Billion by 2032.

Livestock medicine is becoming a strategic pillar of resilient animal agriculture as producers, veterinarians, regulators, and food-chain stakeholders respond to rising demand for safe animal protein, persistent transboundary animal disease risks, antimicrobial resistance, and climate-related stress on herds and flocks. The field spans preventive healthcare, vaccines, parasiticides, anti-infectives, diagnostics, reproductive health, nutritional therapeutics, biosecurity, and herd health management across cattle, swine, poultry, sheep, goats, and aquaculture-adjacent production systems. Verified public-health guidance from global animal health authorities consistently emphasizes prevention, surveillance, vaccination, responsible antimicrobial use, and rapid outbreak response as essential to protecting animal welfare and food security. In this environment, livestock medicine is shifting from episodic treatment toward integrated, evidence-led population medicine, supported by diagnostics, digital records, farm-level monitoring, and stronger veterinary oversight.

Transformative Shifts in the Livestock Medicine Landscape

The livestock medicine landscape is being reshaped by four major forces: disease pressure, regulatory modernization, sustainability expectations, and digital transformation. Outbreaks of avian influenza, African swine fever, foot-and-mouth disease, lumpy skin disease, and endemic respiratory and enteric infections continue to reinforce the value of vaccination, surveillance, and biosecurity. At the same time, antimicrobial stewardship policies are tightening across many jurisdictions, encouraging veterinarians and producers to adopt diagnostics-led treatment, improved husbandry, vaccination programs, and alternatives that reduce unnecessary antimicrobial exposure. Food retailers, processors, and export markets are also placing greater emphasis on traceability, animal welfare, residue control, and environmental performance. These shifts are accelerating demand for integrated herd health programs, cold-chain reliability for biologics, point-of-care diagnostics, disease monitoring systems, and preventive medicine protocols that align productivity with public health and sustainability goals.

Cumulative Impact of Artificial Intelligence on Livestock Medicine

Artificial intelligence is beginning to alter how livestock medicine is delivered, particularly in disease detection, precision treatment, biosecurity monitoring, and veterinary decision support. AI-enabled image recognition, acoustic monitoring, wearable sensors, and computer vision can help identify early signs of lameness, respiratory distress, heat stress, abnormal feeding behavior, and reproductive events before clinical losses escalate. Predictive analytics can combine veterinary records, weather data, movement data, production metrics, and laboratory results to flag herd-level disease risks and guide targeted interventions. AI also supports antimicrobial stewardship by helping veterinarians evaluate treatment histories, susceptibility results, withdrawal periods, and recurrence patterns. However, adoption depends on data quality, interoperability, farm connectivity, cybersecurity, veterinary validation, and ethical governance. The greatest value is expected where AI augments rather than replaces clinical judgment, enabling earlier intervention, stronger surveillance, and more efficient use of vaccines, diagnostics, and therapeutics.

Key Regional Insights Across Livestock Medicine

Asia-Pacific is a critical center for livestock medicine due to its large and diverse animal protein systems, ranging from intensive poultry and swine operations to smallholder dairy and mixed farming. The region faces recurring pressure from avian influenza, swine diseases, parasitic infections, and zoonotic disease concerns, making vaccination, diagnostics, biosecurity, and veterinary access central priorities. North America is characterized by advanced veterinary infrastructure, strong regulatory oversight, established herd health programs, and broad use of diagnostics, vaccines, prescription animal medicines, and digital production records, with antimicrobial stewardship and traceability shaping purchasing and treatment practices. Latin America remains highly important for cattle, poultry, and swine production, with Brazil and Mexico reinforcing demand for disease prevention, parasite control, reproductive health, and export-compliant residue management. Europe places strong emphasis on animal welfare, reduced antimicrobial dependence, pharmacovigilance, and preventive veterinary medicine, supported by strict food-safety and veterinary medicine regulations. The Middle East prioritizes food security, high-value dairy, poultry, camel, and small ruminant health, with heat stress, import dependence, and biosecurity influencing veterinary product and service needs. Africa presents a dual landscape of commercial livestock expansion and smallholder dependence, where livestock medicine is closely tied to food security, rural livelihoods, vaccination campaigns, parasite control, and improved access to veterinary diagnostics and cold-chain distribution.

Key Group Insights Across Livestock Medicine

ASEAN livestock medicine priorities are shaped by dense poultry and swine production, smallholder farming, tropical disease pressure, and the need for stronger surveillance and biosecurity across cross-border value chains. GCC countries emphasize veterinary solutions that support food security, intensive dairy and poultry systems, camel and small ruminant health, and adaptation to heat stress and water scarcity. The European Union continues to influence global livestock medicine standards through stringent rules on veterinary medicinal products, antimicrobial use, animal welfare, residue monitoring, and farm-to-fork safety, encouraging preventive care and documented treatment protocols. BRICS economies combine large livestock populations, expanding animal protein consumption, and significant disease-management needs, making vaccines, anti-parasitics, diagnostics, and herd health services central to productivity and resilience. G7 countries are prominent in high-standard veterinary governance, advanced diagnostics, surveillance systems, antimicrobial stewardship, and innovation adoption, with strong emphasis on One Health alignment. NATO member states, while diverse in livestock systems, share heightened attention to supply-chain resilience, biosecurity, food security, and disease preparedness, particularly where agricultural continuity intersects with national resilience planning.

Key Country Insights Across Livestock Medicine

The United States has a highly developed livestock medicine ecosystem supported by large-scale cattle, swine, poultry, and dairy operations, veterinary prescription oversight, disease surveillance, and growing adoption of digital herd health tools. Canada emphasizes biosecurity, responsible antimicrobial use, dairy and beef herd health, and strong food-safety compliance across integrated production chains. Mexico’s livestock medicine priorities include cattle and poultry health, vaccination, parasite control, and trade-linked disease monitoring. Brazil is a major animal protein producer where livestock medicine is closely tied to beef, poultry, swine, reproductive performance, endemic disease control, and export-market compliance. The United Kingdom maintains strong standards in animal welfare, veterinary oversight, residue control, and antimicrobial stewardship, while Germany and France place strong emphasis on regulated veterinary medicine use, preventive livestock health, diagnostics, and food-chain safety. Russia’s livestock medicine needs are influenced by large poultry, swine, and cattle production systems, disease prevention, and domestic food security priorities. Italy and Spain combine intensive livestock production with strict European veterinary regulations, supporting demand for vaccines, biosecurity, and animal welfare-compliant treatment. China is a major driver of livestock health transformation due to intensive swine, poultry, dairy, and aquaculture-linked protein systems, with strong focus on disease control, vaccination, and biosecurity after major animal disease disruptions. India’s livestock medicine landscape is shaped by one of the world’s largest dairy animal bases, smallholder production, vaccination programs, parasitic disease management, and growing veterinary access needs. Japan prioritizes high-biosecurity livestock systems, food safety, traceability, and advanced veterinary care, while Australia emphasizes extensive cattle and sheep production, disease freedom status, parasite management, and export assurance. South Korea’s livestock medicine priorities include high-density swine and poultry production, rapid disease response, vaccination, and technologically enabled farm monitoring.

Actionable Recommendations for Livestock Medicine Leaders

Industry leaders should prioritize preventive livestock healthcare strategies that combine vaccination, diagnostics, parasite control, reproductive management, nutrition, and biosecurity into integrated herd and flock health programs. Veterinary medicine portfolios should align with antimicrobial stewardship by supporting diagnostics-led treatment, susceptibility testing, withdrawal-period compliance, and alternatives that reduce avoidable antimicrobial exposure. Investment in cold-chain integrity, last-mile veterinary access, and training for farm personnel can improve outcomes, especially in regions with fragmented production systems. Digital tools should be adopted where they provide measurable clinical value, such as early disease detection, treatment documentation, traceability, and welfare monitoring. Leaders should also strengthen pharmacovigilance, regulatory compliance, and residue-management systems to support food safety and export readiness. Collaboration with veterinarians, producer groups, laboratories, universities, and public agencies can enhance surveillance, improve outbreak preparedness, and accelerate adoption of evidence-based livestock medicine practices.

Research Methodology

This executive summary is developed through a secondary research-led methodology focused on verified, data-backed information from public veterinary authorities, animal health regulators, food-safety agencies, peer-reviewed scientific literature, agricultural policy sources, and internationally recognized One Health guidance. The analysis emphasizes qualitative assessment of disease dynamics, regulatory direction, antimicrobial stewardship, animal welfare standards, technology adoption, and regional livestock production characteristics. Sources are evaluated for credibility, recency, methodological transparency, and relevance to livestock medicine across species and geographies. The approach intentionally excludes market sizing, market share, and forecasting, focusing instead on evidence-based drivers, constraints, regional patterns, and strategic implications for industry decision-makers.

Conclusion

Livestock medicine is entering a more preventive, data-enabled, and stewardship-driven era. Disease preparedness, vaccination, diagnostics, responsible antimicrobial use, animal welfare, and traceability are now central to livestock productivity and food-system resilience. Regional priorities differ, from high-standard regulatory compliance in Europe and North America to access expansion and disease-control needs across Asia-Pacific, Latin America, Africa, and the Middle East. Artificial intelligence and digital monitoring can strengthen veterinary decision-making when grounded in validated data and practical farm workflows. Organizations that align livestock medicine strategies with One Health principles, biosecurity, regulatory compliance, and producer-level usability will be best positioned to support healthier animals, safer food, and more resilient agricultural systems.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Livestock Medicine Market, by Product Type
7.1. Introduction
7.2. Anti-inflammatory Agents
7.3. Antibiotics
7.3.1. Cephalosporins
7.3.2. Penicillins
7.3.3. Tetracyclines
7.4. Antiparasitic Agents
7.4.1. Ectoparasiticides
7.4.2. Endoparasiticides
7.5. Feed Additives
7.5.1. Prebiotics
7.5.2. Probiotics
7.6. Hormones
7.6.1. Growth Hormones
7.6.2. Reproductive Hormones
7.7. Vaccines
7.7.1. Inactivated Vaccines
7.7.2. Live Attenuated Vaccines
7.7.3. Subunit Vaccines
8. Livestock Medicine Market, by Disease Type
8.1. Introduction
8.2. Infectious Diseases
8.3. Metabolic Diseases
8.4. Nutritional Deficiency Diseases
8.5. Parasitic Diseases
8.6. Reproductive Diseases
9. Livestock Medicine Market, by Animal Type
9.1. Introduction
9.2. Aquaculture
9.3. Cattle
9.4. Goats
9.5. Poultry
9.6. Sheep
9.7. Swine
10. Livestock Medicine Market, by Formulation
10.1. Introduction
10.2. Capsules
10.3. Gels
10.4. Liquids
10.5. Powders
10.6. Tablets
11. Livestock Medicine Market, by Route of Administration
11.1. Introduction
11.2. Inhalation
11.3. Injectable
11.3.1. Intramuscular
11.3.2. Intravenous
11.4. Oral
11.4.1. Liquids
11.4.2. Tablets
11.5. Topical
11.5.1. Creams
11.5.2. Patches
12. Livestock Medicine Market, by End Users
12.1. Introduction
12.2. Livestock Farmers
12.3. Veterinary Clinics
12.4. Veterinary Hospitals
13. Livestock Medicine Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Livestock Medicine Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Livestock Medicine Market, by Country
15.1. Introduction
15.2. United States
15.3. Germany
15.4. China
15.5. United Kingdom
15.6. India
15.7. Japan
15.8. Russia
15.9. Brazil
15.10. Canada
15.11. Italy
15.12. Mexico
15.13. France
15.14. Spain
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. AdvaCare Pharma USA
17.2. Anicon Labor GmbH by SAN Group GmbH
17.3. AniCura Group by Mars Petcare
17.4. Bimeda Holdings Limited
17.5. Biogenesis Bago SA
17.6. Boehringer Ingelheim International GmbH
17.7. Calier Laboratories S.A.
17.8. Cargill, Incorporated
17.9. Ceva Sante Animale
17.10. Dechra Pharmaceuticals PLC
17.11. Elanco Animal Health Incorporated
17.12. HESTER BIOSCIENCES LIMITED
17.13. HIPRA S.A.
17.14. HUVEPHARMA EOOD
17.15. Indian Immunologicals Ltd.
17.16. Merck KGaA
17.17. Neogen Corporation
17.18. Norbrook Group
17.19. Parnell Pharmaceuticals Holdings Ltd.
17.20. Phibro Animal Health Corporation
17.21. Vetoquinol S.A.
17.22. Vetpharma Animal Health S.L.
17.23. Vetpro Healthcare
17.24. Virbac SA
17.25. Zoetis Inc.
18. Key Experts
List of Figures
FIGURE 1. Global Livestock Medicine Market, Years Considered for the Study
FIGURE 2. Global Livestock Medicine Market, Research Design
FIGURE 3. Global Livestock Medicine Market, Research Framework
FIGURE 4. Global Livestock Medicine Market, Data Triangulation
FIGURE 5. Global Livestock Medicine Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Livestock Medicine Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Livestock Medicine Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Livestock Medicine Market Size, by Disease Type, 2025 vs 2032 (%)
FIGURE 9. Global Livestock Medicine Market Size, by Disease Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Livestock Medicine Market Size, by Animal Type, 2025 vs 2032 (%)
FIGURE 11. Global Livestock Medicine Market Size, by Animal Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Livestock Medicine Market Size, by Formulation, 2025 vs 2032 (%)
FIGURE 13. Global Livestock Medicine Market Size, by Formulation, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Livestock Medicine Market Size, by Route of Administration, 2025 vs 2032 (%)
FIGURE 15. Global Livestock Medicine Market Size, by Route of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Livestock Medicine Market Size, by End Users, 2025 vs 2032 (%)
FIGURE 17. Global Livestock Medicine Market Size, by End Users, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Livestock Medicine Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Livestock Medicine Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Livestock Medicine Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Livestock Medicine Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Livestock Medicine Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Livestock Medicine Market Share, by Key Player, 2025
List of Tables
TABLE 1. Global Livestock Medicine Market Segmentation & Coverage
TABLE 2. Global Livestock Medicine Market Size, 2017-2032 (USD Million)
TABLE 3. Global Livestock Medicine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Anti-inflammatory Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Anti-inflammatory Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Anti-inflammatory Agents Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Antibiotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Antibiotics Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Antibiotics Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Cephalosporins Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Cephalosporins Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Cephalosporins Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Penicillins Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Penicillins Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Penicillins Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Tetracyclines Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Tetracyclines Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Tetracyclines Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Antiparasitic Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Antiparasitic Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Antiparasitic Agents Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Ectoparasiticides Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Ectoparasiticides Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Ectoparasiticides Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Endoparasiticides Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Endoparasiticides Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Endoparasiticides Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Feed Additives Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Feed Additives Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Feed Additives Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Prebiotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Prebiotics Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Prebiotics Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Probiotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Probiotics Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Probiotics Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Hormones Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Hormones Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Hormones Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Growth Hormones Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Growth Hormones Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Growth Hormones Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Reproductive Hormones Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Reproductive Hormones Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Reproductive Hormones Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Inactivated Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Inactivated Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Inactivated Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Live Attenuated Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Live Attenuated Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Live Attenuated Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Subunit Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Subunit Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Subunit Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Livestock Medicine Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 59. Global Infectious Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Infectious Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Infectious Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Metabolic Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Metabolic Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Metabolic Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Nutritional Deficiency Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Nutritional Deficiency Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Nutritional Deficiency Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Parasitic Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Parasitic Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Parasitic Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Reproductive Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Reproductive Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Reproductive Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Livestock Medicine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 75. Global Aquaculture Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Aquaculture Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Aquaculture Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Cattle Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Cattle Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Cattle Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Goats Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Goats Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Goats Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Poultry Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Poultry Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Poultry Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Sheep Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Sheep Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Sheep Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Swine Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Swine Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Swine Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Livestock Medicine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 94. Global Capsules Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Capsules Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Capsules Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Gels Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Gels Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Gels Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Liquids Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Liquids Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Liquids Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Powders Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Powders Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Powders Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Tablets Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Livestock Medicine Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 110. Global Inhalation Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Global Inhalation Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. Global Inhalation Market Size, by Country, 2017-2032 (USD Million)
TABLE 113. Global Injectable Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Injectable Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Injectable Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Intramuscular Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Intramuscular Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Intramuscular Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Intravenous Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global Intravenous Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global Intravenous Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 125. Global Liquids Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Global Liquids Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. Global Liquids Market Size, by Country, 2017-2032 (USD Million)
TABLE 128. Global Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Global Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. Global Tablets Market Size, by Country, 2017-2032 (USD Million)
TABLE 131. Global Topical Market Size, by Region, 2017-2032 (USD Million)
TABLE 132. Global Topical Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. Global Topical Market Size, by Country, 2017-2032 (USD Million)
TABLE 134. Global Creams Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. Global Creams Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. Global Creams Market Size, by Country, 2017-2032 (USD Million)
TABLE 137. Global Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 138. Global Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 139. Global Patches Market Size, by Country, 2017-2032 (USD Million)
TABLE 140. Global Livestock Medicine Market Size, by End Users, 2017-2032 (USD Million)
TABLE 141. Global Livestock Farmers Market Size, by Region, 2017-2032 (USD Million)
TABLE 142. Global Livestock Farmers Market Size, by Group, 2017-2032 (USD Million)
TABLE 143. Global Livestock Farmers Market Size, by Country, 2017-2032 (USD Million)
TABLE 144. Global Veterinary Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 145. Global Veterinary Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 146. Global Veterinary Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 147. Global Veterinary Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 148. Global Veterinary Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 149. Global Veterinary Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 150. Global Livestock Medicine Market Size, by Region, 2017-2032 (USD Million)
TABLE 151. Asia-Pacific Livestock Medicine Market Size, by Region, 2017-2032 (USD Million)
TABLE 152. Asia-Pacific Livestock Medicine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 153. Asia-Pacific Livestock Medicine Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 154. Asia-Pacific Livestock Medicine Market Size, by Antiparasitic Agents, 2017-2032 (USD Million)
TABLE 155. Asia-Pacific Livestock Medicine Market Size, by Feed Additives, 2017-2032 (USD Million)
TABLE 156. Asia-Pacific Livestock Medicine Market Size, by Hormones, 2017-2032 (USD Million)
TABLE 157. Asia-Pacific Livestock Medicine Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 158. Asia-Pacific Livestock Medicine Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 159. Asia-Pacific Livestock Medicine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 160. Asia-Pacific Livestock Medicine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 161. Asia-Pacific Livestock Medicine Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 162. Asia-Pacific Livestock Medicine Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 163. Asia-Pacific Livestock Medicine Market Size, by Oral, 2017-2032 (USD Million)
TABLE 164. Asia-Pacific Livestock Medicine Market Size, by Topical, 2017-2032 (USD Million)
TABLE 165. Asia-Pacific Livestock Medicine Market Size, by End Users, 2017-2032 (USD Million)
TABLE 166. North America Livestock Medicine Market Size, by Region, 2017-2032 (USD Million)
TABLE 167. North America Livestock Medicine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 168. North America Livestock Medicine Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 169. North America Livestock Medicine Market Size, by Antiparasitic Agents, 2017-2032 (USD Million)
TABLE 170. North America Livestock Medicine Market Size, by Feed Additives, 2017-2032 (USD Million)
TABLE 171. North America Livestock Medicine Market Size, by Hormones, 2017-2032 (USD Million)
TABLE 172. North America Livestock Medicine Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 173. North America Livestock Medicine Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 174. North America Livestock Medicine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 175. North America Livestock Medicine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 176. North America Livestock Medicine Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 177. North America Livestock Medicine Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 178. North America Livestock Medicine Market Size, by Oral, 2017-2032 (USD Million)
TABLE 179. North America Livestock Medicine Market Size, by Topical, 2017-2032 (USD Million)
TABLE 180. North America Livestock Medicine Market Size, by End Users, 2017-2032 (USD Million)
TABLE 181. Latin America Livestock Medicine Market Size, by Region, 2017-2032 (USD Million)
TABLE 182. Latin America Livestock Medicine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 183. Latin America Livestock Medicine Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 184. Latin America Livestock Medicine Market Size, by Antiparasitic Agents, 2017-2032 (USD Million)
TABLE 185. Latin America Livestock Medicine Market Size, by Feed Additives, 2017-2032 (USD Million)
TABLE 186. Latin America Livestock Medicine Market Size, by Hormones, 2017-2032 (USD Million)
TABLE 187. Latin America Livestock Medicine Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 188. Latin America Livestock Medicine Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 189. Latin America Livestock Medicine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 190. Latin America Livestock Medicine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 191. Latin America Livestock Medicine Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 192. Latin America Livestock Medicine Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 193. Latin America Livestock Medicine Market Size, by Oral, 2017-2032 (USD Million)
TABLE 194. Latin America Livestock Medicine Market Size, by Topical, 2017-2032 (USD Million)
TABLE 195. Latin America Livestock Medicine Market Size, by End Users, 2017-2032 (USD Million)
TABLE 196. Europe Livestock Medicine Market Size, by Region, 2017-2032 (USD Million)
TABLE 197. Europe Livestock Medicine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 198. Europe Livestock Medicine Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 199. Europe Livestock Medicine Market Size, by Antiparasitic Agents, 2017-2032 (USD Million)
TABLE 200. Europe Livestock Medicine Market Size, by Feed Additives, 2017-2032 (USD Million)
TABLE 201. Europe Livestock Medicine Market Size, by Hormones, 2017-2032 (USD Million)
TABLE 202. Europe Livestock Medicine Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 203. Europe Livestock Medicine Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 204. Europe Livestock Medicine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 205. Europe Livestock Medicine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 206. Europe Livestock Medicine Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 207. Europe Livestock Medicine Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 208. Europe Livestock Medicine Market Size, by Oral, 2017-2032 (USD Million)
TABLE 209. Europe Livestock Medicine Market Size, by Topical, 2017-2032 (USD Million)
TABLE 210. Europe Livestock Medicine Market Size, by End Users, 2017-2032 (USD Million)
TABLE 211. Middle East Livestock Medicine Market Size, by Region, 2017-2032 (USD Million)
TABLE 212. Middle East Livestock Medicine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 213. Middle East Livestock Medicine Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 214. Middle East Livestock Medicine Market Size, by Antiparasitic Agents, 2017-2032 (USD Million)
TABLE 215. Middle East Livestock Medicine Market Size, by Feed Additives, 2017-2032 (USD Million)
TABLE 216. Middle East Livestock Medicine Market Size, by Hormones, 2017-2032 (USD Million)
TABLE 217. Middle East Livestock Medicine Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 218. Middle East Livestock Medicine Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 219. Middle East Livestock Medicine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 220. Middle East Livestock Medicine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 221. Middle East Livestock Medicine Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 222. Middle East Livestock Medicine Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 223. Middle East Livestock Medicine Market Size, by Oral, 2017-2032 (USD Million)
TABLE 224. Middle East Livestock Medicine Market Size, by Topical, 2017-2032 (USD Million)
TABLE 225. Middle East Livestock Medicine Market Size, by End Users, 2017-2032 (USD Million)
TABLE 226. Africa Livestock Medicine Market Size, by Region, 2017-2032 (USD Million)
TABLE 227. Africa Livestock Medicine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 228. Africa Livestock Medicine Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 229. Africa Livestock Medicine Market Size, by Antiparasitic Agents, 2017-2032 (USD Million)
TABLE 230. Africa Livestock Medicine Market Size, by Feed Additives, 2017-2032 (USD Million)
TABLE 231. Africa Livestock Medicine Market Size, by Hormones, 2017-2032 (USD Million)
TABLE 232. Africa Livestock Medicine Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 233. Africa Livestock Medicine Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 234. Africa Livestock Medicine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 235. Africa Livestock Medicine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 236. Africa Livestock Medicine Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 237. Africa Livestock Medicine Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 238. Africa Livestock Medicine Market Size, by Oral, 2017-2032 (USD Million)
TABLE 239. Africa Livestock Medicine Market Size, by Topical, 2017-2032 (USD Million)
TABLE 240. Africa Livestock Medicine Market Size, by End Users, 2017-2032 (USD Million)
TABLE 241. Global Livestock Medicine Market Size, by Group, 2017-2032 (USD Million)
TABLE 242. ASEAN Livestock Medicine Market Size, by Group, 2017-2032 (USD Million)
TABLE 243. ASEAN Livestock Medicine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 244. ASEAN Livestock Medicine Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 245. ASEAN Livestock Medicine Market Size, by Antiparasitic Agents, 2017-2032 (USD Million)
TABLE 246. ASEAN Livestock Medicine Market Size, by Feed Additives, 2017-2032 (USD Million)
TABLE 247. ASEAN Livestock Medicine Market Size, by Hormones, 2017-2032 (USD Million)
TABLE 248. ASEAN Livestock Medicine Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 249. ASEAN Livestock Medicine Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 250. ASEAN Livestock Medicine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 251. ASEAN Livestock Medicine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 252. ASEAN Livestock Medicine Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 253. ASEAN Livestock Medicine Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 254. ASEAN Livestock Medicine Market Size, by Oral, 2017-2032 (USD Million)
TABLE 255. ASEAN Livestock Medicine Market Size, by Topical, 2017-2032 (USD Million)
TABLE 256. ASEAN Livestock Medicine Market Size, by End Users, 2017-2032 (USD Million)
TABLE 257. GCC Livestock Medicine Market Size, by Group, 2017-2032 (USD Million)
TABLE 258. GCC Livestock Medicine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 259. GCC Livestock Medicine Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 260. GCC Livestock Medicine Market Size, by Antiparasitic Agents, 2017-2032 (USD Million)
TABLE 261. GCC Livestock Medicine Market Size, by Feed Additives, 2017-2032 (USD Million)
TABLE 262. GCC Livestock Medicine Market Size, by Hormones, 2017-2032 (USD Million)
TABLE 263. GCC Livestock Medicine Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 264. GCC Livestock Medicine Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 265. GCC Livestock Medicine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 266. GCC Livestock Medicine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 267. GCC Livestock Medicine Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 268. GCC Livestock Medicine Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 269. GCC Livestock Medicine Market Size, by Oral, 2017-2032 (USD Million)
TABLE 270. GCC Livestock Medicine Market Size, by Topical, 2017-2032 (USD Million)
TABLE 271. GCC Livestock Medicine Market Size, by End Users, 2017-2032 (USD Million)
TABLE 272. European Union Livestock Medicine Market Size, by Group, 2017-2032 (USD Million)
TABLE 273. European Union Livestock Medicine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 274. European Union Livestock Medicine Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 275. European Union Livestock Medicine Market Size, by Antiparasitic Agents, 2017-2032 (USD Million)
TABLE 276. European Union Livestock Medicine Market Size, by Feed Additives, 2017-2032 (USD Million)
TABLE 277. European Union Livestock Medicine Market Size, by Hormones, 2017-2032 (USD Million)
TABLE 278. European Union Livestock Medicine Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 279. European Union Livestock Medicine Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 280. European Union Livestock Medicine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 281. European Union Livestock Medicine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 282. European Union Livestock Medicine Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 283. European Union Livestock Medicine Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 284. European Union Livestock Medicine Market Size, by Oral, 2017-2032 (USD Million)
TABLE 285. European Union Livestock Medicine Market Size, by Topical, 2017-2032 (USD Million)
TABLE 286. European Union Livestock Medicine Market Size, by End Users, 2017-2032 (USD Million)
TABLE 287. BRICS Livestock Medicine Market Size, by Group, 2017-2032 (USD Million)
TABLE 288. BRICS Livestock Medicine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 289. BRICS Livestock Medicine Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 290. BRICS Livestock Medicine Market Size, by Antiparasitic Agents, 2017-2032 (USD Million)
TABLE 291. BRICS Livestock Medicine Market Size, by Feed Additives, 2017-2032 (USD Million)
TABLE 292. BRICS Livestock Medicine Market Size, by Hormones, 2017-2032 (USD Million)
TABLE 293. BRICS Livestock Medicine Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 294. BRICS Livestock Medicine Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 295. BRICS Livestock Medicine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 296. BRICS Livestock Medicine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 297. BRICS Livestock Medicine Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 298. BRICS Livestock Medicine Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 299. BRICS Livestock Medicine Market Size, by Oral, 2017-2032 (USD Million)
TABLE 300. BRICS Livestock Medicine Market Size, by Topical, 2017-2032 (USD Million)
TABLE 301. BRICS Livestock Medicine Market Size, by End Users, 2017-2032 (USD Million)
TABLE 302. G7 Livestock Medicine Market Size, by Group, 2017-2032 (USD Million)
TABLE 303. G7 Livestock Medicine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 304. G7 Livestock Medicine Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 305. G7 Livestock Medicine Market Size, by Antiparasitic Agents, 2017-2032 (USD Million)
TABLE 306. G7 Livestock Medicine Market Size, by Feed Additives, 2017-2032 (USD Million)
TABLE 307. G7 Livestock Medicine Market Size, by Hormones, 2017-2032 (USD Million)
TABLE 308. G7 Livestock Medicine Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 309. G7 Livestock Medicine Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 310. G7 Livestock Medicine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 311. G7 Livestock Medicine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 312. G7 Livestock Medicine Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 313. G7 Livestock Medicine Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 314. G7 Livestock Medicine Market Size, by Oral, 2017-2032 (USD Million)
TABLE 315. G7 Livestock Medicine Market Size, by Topical, 2017-2032 (USD Million)
TABLE 316. G7 Livestock Medicine Market Size, by End Users, 2017-2032 (USD Million)
TABLE 317. NATO Livestock Medicine Market Size, by Group, 2017-2032 (USD Million)
TABLE 318. NATO Livestock Medicine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 319. NATO Livestock Medicine Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 320. NATO Livestock Medicine Market Size, by Antiparasitic Agents, 2017-2032 (USD Million)
TABLE 321. NATO Livestock Medicine Market Size, by Feed Additives, 2017-2032 (USD Million)
TABLE 322. NATO Livestock Medicine Market Size, by Hormones, 2017-2032 (USD Million)
TABLE 323. NATO Livestock Medicine Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 324. NATO Livestock Medicine Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 325. NATO Livestock Medicine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 326. NATO Livestock Medicine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 327. NATO Livestock Medicine Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 328. NATO Livestock Medicine Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 329. NATO Livestock Medicine Market Size, by Oral, 2017-2032 (USD Million)
TABLE 330. NATO Livestock Medicine Market Size, by Topical, 2017-2032 (USD Million)
TABLE 331. NATO Livestock Medicine Market Size, by End Users, 2017-2032 (USD Million)
TABLE 332. Global Livestock Medicine Market Size, by Country, 2017-2032 (USD Million)
TABLE 333. United States Livestock Medicine Market Size, 2017-2032 (USD Million)
TABLE 334. United States Livestock Medicine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 335. United States Livestock Medicine Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 336. United States Livestock Medicine Market Size, by Antiparasitic Agents, 2017-2032 (USD Million)
TABLE 337. United States Livestock Medicine Market Size, by Feed Additives, 2017-2032 (USD Million)
TABLE 338. United States Livestock Medicine Market Size, by Hormones, 2017-2032 (USD Million)
TABLE 339. United States Livestock Medicine Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 340. United States Livestock Medicine Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 341. United States Livestock Medicine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 342. United States Livestock Medicine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 343. United States Livestock Medicine Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 344. United States Livestock Medicine Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 345. United States Livestock Medicine Market Size, by Oral, 2017-2032 (USD Million)
TABLE 346. United States Livestock Medicine Market Size, by Topical, 2017-2032 (USD Million)
TABLE 347. United States Livestock Medicine Market Size, by End Users, 2017-2032 (USD Million)
TABLE 348. Germany Livestock Medicine Market Size, 2017-2032 (USD Million)
TABLE 349. Germany Livestock Medicine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 350. Germany Livestock Medicine Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 351. Germany Livestock Medicine Market Size, by Antiparasitic Agents, 2017-2032 (USD Million)
TABLE 352. Germany Livestock Medicine Market Size, by Feed Additives, 2017-2032 (USD Million)
TABLE 353. Germany Livestock Medicine Market Size, by Hormones, 2017-2032 (USD Million)
TABLE 354. Germany Livestock Medicine Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 355. Germany Livestock Medicine Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 356. Germany Livestock Medicine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 357. Germany Livestock Medicine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 358. Germany Livestock Medicine Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 359. Germany Livestock Medicine Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 360. Germany Livestock Medicine Market Size, by Oral, 2017-2032 (USD Million)
TABLE 361. Germany Livestock Medicine Market Size, by Topical, 2017-2032 (USD Million)
TABLE 362. Germany Livestock Medicine Market Size, by End Users, 2017-2032 (USD Million)
TABLE 363. China Livestock Medicine Market Size, 2017-2032 (USD Million)
TABLE 364. China Livestock Medicine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 365. China Livestock Medicine Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 366. China Livestock Medicine Market Size, by Antiparasitic Agents, 2017-2032 (USD Million)
TABLE 367. China Livestock Medicine Market Size, by Feed Additives, 2017-2032 (USD Million)
TABLE 368. China Livestock Medicine Market Size, by Hormones, 2017-2032 (USD Million)
TABLE 369. China Livestock Medicine Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 370. China Livestock Medicine Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 371. China Livestock Medicine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 372. China Livestock Medicine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 373. China Livestock Medicine Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 374. China Livestock Medicine Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 375. China Livestock Medicine Market Size, by Oral, 2017-2032 (USD Million)
TABLE 376. China Livestock Medicine Market Size, by Topical, 2017-2032 (USD Million)
TABLE 377. China Livestock Medicine Market Size, by End Users, 2017-2032 (USD Million)
TABLE 378. United Kingdom Livestock Medicine Mark

Companies Mentioned

  • AdvaCare Pharma USA
  • Anicon Labor GmbH by SAN Group GmbH
  • AniCura Group by Mars Petcare
  • Bimeda Holdings Limited
  • Biogenesis Bago SA
  • Boehringer Ingelheim International GmbH
  • Calier Laboratories S.A.
  • Cargill, Incorporated
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • HESTER BIOSCIENCES LIMITED
  • HIPRA S.A.
  • HUVEPHARMA EOOD
  • Indian Immunologicals Ltd.
  • Merck KGaA
  • Neogen Corporation
  • Norbrook Group
  • Parnell Pharmaceuticals Holdings Ltd.
  • Phibro Animal Health Corporation
  • Vetoquinol S.A.
  • Vetpharma Animal Health S.L.
  • Vetpro Healthcare
  • Virbac SA
  • Zoetis Inc.

Table Information

Report AttributeDetails
No. of Pages192
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 21.95 Billion
Forecasted Market Value ( USD ) by 2032 $ 30.72 Billion
Compound Annual Growth Rate5.7%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Live Animals Market Report 2026 - Product Image

Live Animals Market Report 2026

  • Report
  • 250 Pages
  • Global
From
North America Livestock Insurance Market Outlook, 2031 - Product Image

North America Livestock Insurance Market Outlook, 2031

  • Report
  • 85 Pages
  • North America
From
Asia-Pacific Livestock Insurance Market, By Country, Competition, Forecast & Opportunities, 2020-2030F - Product Image

Asia-Pacific Livestock Insurance Market, By Country, Competition, Forecast & Opportunities, 2020-2030F

  • Report
  • 132 Pages
  • Asia Pacific
From
Livestock Vaccines Market - Global Strategic Business Report - Product Image

Livestock Vaccines Market - Global Strategic Business Report

  • Report
  • 477 Pages
  • Global
From
Anti-Infective Agents for Livestock Market - Global Forecast 2026-2032 - Product Image

Anti-Infective Agents for Livestock Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.